Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2024 Earnings Call Transcript November 6, 2024
Arbutus Biopharma Corporation reports earnings inline with expectations. Reported EPS is $-0.1 EPS, expectations were $-0.1.
Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma 2024 Third Quarter Financial Results and Corporate Update. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to...
